Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASLAN001 Plus Capecitabine in HER2+ Breast Cancer with CNS Metastases
NCT07166367Phase 2Terminated
- Sponsor
- National Cancer Centre Singapore
- Start
- Aug 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varlitinib in breast cancer, sponsored by National Cancer Centre Singapore. Started Aug 2016; status: terminated.
02
Drugs
varlitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07166367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07166367.